Supreme Court Restores Restrictions on Biosimilar Drug Marketing: Genentech Inc. vs. Drug Controller General of India (2019)
Supreme Court Restores Restrictions on Biosimilar Drug Marketing: Genentech Inc. vs. Drug Controller General of India (2019) LEGAL ISSUE: Whether a biosimilar drug manufacturer can market their product with the same name as the original drug, despite not conducting all required tests and trials. CASE TYPE: Pharmaceutical Law, Intellectual Property Case Name: M/s Genentech Inc. […]